Filter
377
Filtered Results: 377
Text search:
toxicology
Featured
Recommendations
29
New Publications
64
Language
Document type
No document type
189
Guidelines
80
Studies & Reports
72
Manuals
16
Strategic & Response Plan
12
Fact sheets
4
Training Material
2
Situation Updates
2
Countries / Regions
Global
14
Western and Central Europe
13
India
13
Kenya
12
Latin America and the Carribbean
11
Africa
9
Rwanda
5
Syria
5
Namibia
5
Sierra Leone
4
Nigeria
4
USA
4
Venezuela
4
Uganda
4
Brazil
4
Chile
3
Zimbabwe
3
Mozambique
3
Tanzania
3
Germany
3
Paraguay
3
Argentina
3
South Africa
3
Eastern Europe
3
Zambia
3
North Macedonia
2
Ghana
2
Albania
2
Malawi
2
Philippines
2
West and Central Africa
2
Bolivia
2
Bangladesh
2
Sudan
2
Ethiopia
2
Botswana
2
Liberia
2
Madagascar
2
Eswatini/ Swaziland
2
Nepal
1
Ukraine
1
Serbia
1
Lesotho
1
Togo
1
Senegal
1
Morocco
1
Guinea
1
Haiti
1
Asia
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
Southern Africa
1
Nicaragua
1
Moldova
1
Indonesia
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
107
Clinical Guidelines
30
Key Resources
20
Public Health
17
Women & Child Health
9
Pharmacy & Technologies
5
Capacity Building
2
Toolboxes
Mental Health
57
COVID-19
39
Planetary Health
36
Pharmacy
27
Specific Hazards
23
Rapid Response
17
AMR
16
NTDs
13
Conflict
11
TB
10
Ebola
7
NCDs
7
HIV
5
Zika
5
Natural Hazards
4
Disability
4
Caregiver
4
Refugee
3
Global Health Education
3
Cholera
1
Social Ethics
1
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug ...
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Accessed Febr. 6, 2020
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Antibiotic stewardship refers to coordinated efforts and activities that seek to measure and improve use of antibiotics. Implementation of ASPs has demonstrated positive public health and clinical impacts including reducing costs, lengths of hospital stays, and the burden of antibiotic resistance wh...
Event-based surveillance (EBS) is defined as the organized collection, monitoring, assessment and interpretation of mainly unstructured ad hoc information regarding health events or risks, which may represent an acute risk to health. Both indicator-based and event-based surveillance components serve...
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication studies and on WHO risk communication guidelines.
This document is a practical guide to the management of burn injuries for healthcare professionals everyhwere who are non-burn specialistsi
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
